| Company Name: |
Nanjing Chalf-Pharm Technology Co., Ltd.
|
| Tel: |
025-57018978 18251899859 |
| Email: |
sales@chalf-pharm.com |
| Products Intro: |
Product Name:5-(4-HYDROXYBENZYLIDENE)PYRIMIDINE-2,4,6(1H,3H,5H)-TRIONE
CAS:27406-31-1
Purity:95% Package:10KG;1Kg;500g;100g;25g
|
|
| | 5-(4-HYDROXY-BENZYLIDENE)-PYRIMIDINE-2,4,6-TRIONE Basic information |
| Product Name: | 5-(4-HYDROXY-BENZYLIDENE)-PYRIMIDINE-2,4,6-TRIONE | | Synonyms: | IFLAB-BB F1208-0006;5-(4-HYDROXYBENZYLIDENE)BARBITURIC ACID;5-(4-HYDROXYBENZYLIDENE)PYRIMIDINE-2,4,6(1H,3H,5H)-TRIONE;5-(4-HYDROXY-BENZYLIDENE)-PYRIMIDINE-2,4,6-TRIONE;5-(4-HYDROXYBENZYLIDENE)BARBUTIRIC ACID;2,4,6(1H,3H,5H)-Pyrimidinetrione, 5-[(4-hydroxyphenyl)methylene]-;5-(4-hydroxyphenyl)methylenehexahydropyrimidine-2,4,6-trione;MHY-1685 | | CAS: | 27406-31-1 | | MF: | C11H8N2O4 | | MW: | 232.19 | | EINECS: | | | Product Categories: | | | Mol File: | Mol File |  |
| | 5-(4-HYDROXY-BENZYLIDENE)-PYRIMIDINE-2,4,6-TRIONE Chemical Properties |
| storage temp. | Store at -20°C | | solubility | DMSO : 62.5 mg/mL (269.18 mM; Need ultrasonic) |
| | 5-(4-HYDROXY-BENZYLIDENE)-PYRIMIDINE-2,4,6-TRIONE Usage And Synthesis |
| Biological Activity | MHY-1685, a novel mammalian target of rapamycin (mTOR) inhibitor, provides opportunities to improve hCSC-based myocardial regeneration. | | References | [1]. Park JH, et al. Human cardiac stem cells rejuvenated by modulating autophagy with MHY-1685 enhance the therapeutic potential for cardiac repair. Exp Mol Med. 2021 Sep;53(9):1423-1436. |
| | 5-(4-HYDROXY-BENZYLIDENE)-PYRIMIDINE-2,4,6-TRIONE Preparation Products And Raw materials |
|